This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CoreWeave Raises $25B Capital: Fuel for Growth or Leverage Trouble?
by Vaishali Doshi
CRWV has raised $25 billion through debt and equity to fuel data center investments, but soaring interest costs test its profitability.
Will Nebius' 1 GW Capacity Target by 2026 Accelerate Revenue Growth?
by Zacks Equity Research
NBIS boosts ARR outlook to $1.1 billion as it scales data-center capacity. It is targeting 1 GW by 2026 to capture AI-infrastructure demand.
Globant Q2 Earnings & Revenues Beat Estimates, Stock Down
by Zacks Equity Research
GLOB beats Q2 estimates with record pipeline growth, but shares fall 15% as 2025 guidance is trimmed.
CRWV Stock Crashes Post Q2 Earnings: Stay Invested or Make an Exit?
by Vaishali Doshi
CoreWeave shares tumble 33% despite record Q2 revenues, as high leverage, soaring capex, and profit pressures weigh on sentiment.
Globant (GLOB) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Globant (GLOB) delivered earnings and revenue surprises of +0.66% and +0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HeartCore Enterprises, Inc. (HTCR) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HeartCore Enterprises (HTCR) delivered earnings and revenue surprises of +150.00% and +4.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Stay Invested in or Sell Nebius Stock Post Q2 Earnings?
by Vaishali Doshi
NBIS posts massive Q2 growth and ups ARR forecast, but faces stiff competition, high spending and scaling risks ahead.
Can Nebius Reach $1.1B ARR and $630M Revenue Amid AI Boom?
by Zacks Equity Research
NBIS raises 2025 ARR target to $1.1B after Q2 revenue surges 625% on soaring AI infrastructure demand.
Nebius' Q2 Loss Widens Y/Y, Revenues Rise on AI Demand, Stock Up
by Zacks Equity Research
NBIS posts a wider Q2 loss, but a 625% revenue surge and raised ARR guidance highlight growing AI cloud demand.
Should You Hold or Sell CRWV Stock Before Q2 Earnings Release?
by Vaishali Doshi
CoreWeave heads into Q2 earnings with strong demand trends but competition, high capex, and valuation weighing on sentiment.